Prothena Dirección
Dirección controles de criterios 2/4
El CEO de Prothena es Gene Kinney , nombrado en Sep 2016, tiene una permanencia de 8.17 años. compensación anual total es $7.04M, compuesta por 9% salario y 91% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.024% de las acciones de la empresa, por valor de $207.33K. La antigüedad media del equipo directivo y de la junta directiva es de 7.7 años y 5.1 años, respectivamente.
Información clave
Gene Kinney
Chief Executive Officer (CEO)
US$7.0m
Compensación total
| Porcentaje del salario del CEO | 9.0% |
| Permanencia del CEO | 8.2yrs |
| Participación del CEO | 0.02% |
| Permanencia media de la dirección | 7.7yrs |
| Promedio de permanencia en la Junta Directiva | 5.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Prothena (NASDAQ:PRTA) Is In A Good Position To Deliver On Growth Plans
Nov 06
Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade)
Oct 18Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Oct 02Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares
Jul 26Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Jun 19Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials
Jun 07New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)
May 14Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
Feb 23Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%
Feb 08Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?
Dec 20Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business
Nov 24Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk
Oct 27Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Aug 25What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today
May 10We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth
Apr 23Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook
Mar 01We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
Dec 28Prothena: Paying A Premium To Cover All The Alzheimer's Bases
Sep 29Prothena GAAP EPS of -$0.88 misses by $0.31
Aug 08Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$132m |
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$172m |
| Dec 31 2023 | US$7m | US$631k | -US$147m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$141m |
| Mar 31 2023 | n/a | n/a | -US$128m |
| Dec 31 2022 | US$7m | US$601k | -US$117m |
| Sep 30 2022 | n/a | n/a | -US$156m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | n/a | n/a | US$67m |
| Dec 31 2021 | US$5m | US$573k | US$67m |
| Sep 30 2021 | n/a | n/a | US$69m |
| Jun 30 2021 | n/a | n/a | -US$70m |
| Mar 31 2021 | n/a | n/a | -US$124m |
| Dec 31 2020 | US$3m | US$554k | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$80m |
| Dec 31 2019 | US$3m | US$538k | -US$78m |
| Sep 30 2019 | n/a | n/a | -US$79m |
| Jun 30 2019 | n/a | n/a | -US$84m |
| Mar 31 2019 | n/a | n/a | -US$128m |
| Dec 31 2018 | US$11m | US$525k | -US$156m |
| Sep 30 2018 | n/a | n/a | -US$181m |
| Jun 30 2018 | n/a | n/a | -US$209m |
| Mar 31 2018 | n/a | n/a | -US$167m |
| Dec 31 2017 | US$5m | US$521k | -US$153m |
Compensación vs. Mercado: La compensación total de Gene($USD7.04M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD3.15M).
Compensación vs. Ingresos: La compensación de Gene ha aumentado mientras la empresa no es rentable.
CEO
Gene Kinney (55 yo)
8.2yrs
Permanencia
US$7,043,826
Compensación
Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 8.2yrs | US$7.04m | 0.024% $ 207.3k | |
| CFO & Chief Strategy Officer | 11.7yrs | US$2.70m | 0.0060% $ 51.9k | |
| Chief Operating Officer | 3.1yrs | US$2.63m | 0% $ 0 | |
| Chief Regulatory Officer | 7.9yrs | US$2.57m | 0% $ 0 | |
| Chief Accounting Officer & Controller | 11.5yrs | sin datos | sin datos | |
| Chief Scientific Officer | 7.4yrs | US$3.34m | sin datos | |
| Vice President of Investor Relations | no data | sin datos | sin datos | |
| Chief Legal Officer | no data | US$1.18m | sin datos | |
| Chief People Officer | less than a year | sin datos | sin datos | |
| Chief Development Officer | less than a year | sin datos | sin datos | |
| Company Secretary | no data | sin datos | sin datos |
7.7yrs
Permanencia media
55yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de PRTA es experimentado (7.7 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 8.2yrs | US$7.04m | 0.024% $ 207.3k | |
| Independent Director | 2.3yrs | US$896.63k | 0% $ 0 | |
| Independent Director | 11.9yrs | US$912.48k | 0.0023% $ 19.8k | |
| Independent Chairman | less than a year | sin datos | sin datos | |
| Independent Chair Emeritus | less than a year | US$923.48k | 0.00045% $ 3.9k | |
| Independent Director | 11.9yrs | US$917.26k | 0% $ 0 | |
| Independent Director | 11.3yrs | US$901.73k | 0.0078% $ 68.2k | |
| Independent Director | 5.3yrs | US$908.48k | 0% $ 0 | |
| Independent Director | 4.9yrs | sin datos | sin datos | |
| Independent Director | 1.5yrs | US$1.70m | sin datos |
5.1yrs
Permanencia media
62yo
Promedio de edad
Junta con experiencia: La junta directiva de PRTA se considera experimentada (5.1 años de antigüedad promedio).